摘要
尽管大量的抗癌药如今在临床得到使用,因为抗药性而导致的治疗失败是非常频繁的。为了找到防止和避免这样的抵制,鉴定对不同药物的抗药性的作用机制是必要的。的确,新型治疗靶点的识别来克服肿瘤耐药性仍是药物发现和开发中的主要挑战之一。确定耐药性的机制和新型治疗靶点很大程度依赖于肿瘤耐药细胞系的建立。这样一种耐药细胞系的建立过程是艰辛的,耗时的,并且有许多不同的方法报道。这篇综述总结了在肿瘤耐药细胞系创建的方法和耐药机制的鉴定。另外,这篇综述强调了在肿瘤细胞中发现的最频繁的耐药机制
关键词: 获得耐药性,抗癌药物,肿瘤耐药,肿瘤耐药细胞系,同基因细胞系,耐药机制,多重耐药
图形摘要
Current Cancer Drug Targets
Title:Understanding Cancer Drug Resistance by Developing and Studying Resistant Cell Line Models
Volume: 16 Issue: 3
Author(s): Cristina P.R. Xavier, Milica Pesic and M. Helena Vasconcelos
Affiliation:
关键词: 获得耐药性,抗癌药物,肿瘤耐药,肿瘤耐药细胞系,同基因细胞系,耐药机制,多重耐药
摘要: Despite the enormous number of anticancer drugs presently available in the clinic, treatment failure due to drug resistance is very frequent. The identification of mechanisms of resistance to different drugs is necessary, in order to identify ways to prevent and circumvent such resistance. Indeed, the identification of novel therapeutic targets to overcome cancer drug resistance remains one of the major challenges in drug discovery and development. The methods employed to identify drug resistance mechanisms and novel therapeutic targets depend greatly on the establishment of cancer drug resistant cell lines. The establishment of such drug resistant cell lines is laborious and time-consuming and various different approaches have been described. This manuscript reviews the methodologies that have been used to create cancer drug resistant cell lines and to identify their mechanisms of resistance. In addition, this review highlights the most frequent drug resistance mechanisms found in cancer cells.
Export Options
About this article
Cite this article as:
Cristina P.R. Xavier, Milica Pesic and M. Helena Vasconcelos , Understanding Cancer Drug Resistance by Developing and Studying Resistant Cell Line Models, Current Cancer Drug Targets 2016; 16 (3) . https://dx.doi.org/10.2174/1568009616666151113120705
DOI https://dx.doi.org/10.2174/1568009616666151113120705 |
Print ISSN 1568-0096 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-5576 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Azidothymidine is Effective Against Human Multiple Myeloma: A New Use for an Old Drug?
Anti-Cancer Agents in Medicinal Chemistry The Insulin-like Growth Factor-1 Axis and its Potential as a Therapeutic Target in Central Nervous System (CNS) Disorders
Central Nervous System Agents in Medicinal Chemistry Targeting Apoptosis Pathways in Cancer Therapy
Current Cancer Drug Targets Current Therapeutic Paradigms in Glioblastoma
Reviews on Recent Clinical Trials Exosomal miR-214-5p Released from Glioblastoma Cells Modulates Inflammatory Response of Microglia after Lipopolysaccharide Stimulation through Targeting CXCR5
CNS & Neurological Disorders - Drug Targets An Expanding Appreciation of the Role Chemokine Receptors Play in Cancer Progression
Current Pharmaceutical Design The Important Role of Oncolytic Viruses in Common Cancer Treatments
Current Cancer Therapy Reviews The PIK3CA Gene as a Mutated Target for Cancer Therapy
Current Cancer Drug Targets Overview of the Structure and Function of Protein Kinases
Current Enzyme Inhibition Utilizing Ultrasound to Transiently Increase Blood-Brain Barrier Permeability, Modulate of the Tight Junction Proteins, and Alter Cytoskeletal Structure
Current Neurovascular Research New Use for Old Drugs? Prospective Targets of Chloroquines in Cancer Therapy
Current Drug Targets Role of the Renin-Angiotensin System in Gynecologic Cancers
Current Cancer Drug Targets Raman Spectroscopy and Imaging: Promising Optical Diagnostic Tools in Pediatrics
Current Medicinal Chemistry ABC Transporters as Potential Targets for Modulation of Drug Resistance
Mini-Reviews in Medicinal Chemistry Recent Advances in the Use of Metallic Nanoparticles with Antitumoral Action - Review
Current Medicinal Chemistry Biomarkers for Systemic Therapy in Ovarian Cancer
Current Cancer Drug Targets P53 Gene Therapy Sensitizes Resistant Breast Cancer Cells to Doxorubicin Chemotherapy
Drug Delivery Letters Preparation and <I>In Vitro/Vivo</I> Evaluation of Folate-conjugated Pluronic F87-PLGA/TPGS Mixed Nanoparticles for Targeted Drug Delivery
Current Drug Delivery Anti-tumor Therapeutic Molecules that Target the Programmed Cell Death Machinery
Mini-Reviews in Medicinal Chemistry The Delivery of Personalised, Precision Medicines <i>via</i> Synthetic Proteins
Drug Delivery Letters